These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 29162878

  • 1. Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD).
    Srivastava A, Dixit AB, Paul D, Tripathi M, Sarkar C, Chandra PS, Banerjee J.
    Sci Rep; 2017 Nov 21; 7(1):15904. PubMed ID: 29162878
    [Abstract] [Full Text] [Related]

  • 2. Aberrant Expression of miR-323a-5p in Patients with Refractory Epilepsy Caused by Focal Cortical Dysplasia.
    Che N, Zu G, Zhou T, Wang X, Sun Y, Tan Z, Liu Y, Wang D, Luo X, Zhao Z, Zhang Y, Wei M, Yin J.
    Genet Test Mol Biomarkers; 2017 Jan 21; 21(1):3-9. PubMed ID: 27824513
    [Abstract] [Full Text] [Related]

  • 3. The role of histopathologic subtype in the setting of hippocampal sclerosis-associated mesial temporal lobe epilepsy.
    Gales JM, Jehi L, Nowacki A, Prayson RA.
    Hum Pathol; 2017 May 21; 63():79-88. PubMed ID: 28322853
    [Abstract] [Full Text] [Related]

  • 4. Focal Cortical Dysplasia IIIa in Hippocampal Sclerosis-Associated Epilepsy: Anatomo-Electro-Clinical Profile and Surgical Results From a Multicentric Retrospective Study.
    Cossu M, d'Orio P, Barba C, Asioli S, Cardinale F, Casciato S, Caulo M, Colicchio G, Consales A, D'Aniello A, De Benedictis A, De Palma L, Didato G, Di Gennaro G, Di Giacomo R, Esposito V, Guerrini R, Nichelatti M, Revay M, Rizzi M, Vatti G, Villani F, Zamponi N, Tassi L, Marras CE.
    Neurosurgery; 2021 Jan 13; 88(2):384-393. PubMed ID: 32860416
    [Abstract] [Full Text] [Related]

  • 5. Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia.
    Miyata H, Hori T, Vinters HV.
    Neuropathology; 2013 Aug 13; 33(4):442-58. PubMed ID: 23530853
    [Abstract] [Full Text] [Related]

  • 6. Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis.
    Yan S, Zhang H, Xie W, Meng F, Zhang K, Jiang Y, Zhang X, Zhang J.
    Oncotarget; 2017 Jan 17; 8(3):4136-4146. PubMed ID: 27926529
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis.
    Kan Y, Feng L, Si Y, Zhou Z, Wang W, Yang J.
    Neurochem Res; 2022 Nov 17; 47(11):3506-3521. PubMed ID: 35945307
    [Abstract] [Full Text] [Related]

  • 8. Circulating MicroRNAs from Serum Exosomes May Serve as a Putative Biomarker in the Diagnosis and Treatment of Patients with Focal Cortical Dysplasia.
    Chen SD, Pan HY, Huang JB, Liu XP, Li JH, Ho CJ, Tsai MH, Yang JL, Chen SF, Chen NC, Chuang YC.
    Cells; 2020 Aug 10; 9(8):. PubMed ID: 32785072
    [Abstract] [Full Text] [Related]

  • 9. Epilepsy with dual pathology: surgical treatment of cortical dysplasia accompanied by hippocampal sclerosis.
    Kim DW, Lee SK, Nam H, Chu K, Chung CK, Lee SY, Choe G, Kim HK.
    Epilepsia; 2010 Aug 10; 51(8):1429-35. PubMed ID: 19919662
    [Abstract] [Full Text] [Related]

  • 10. Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.
    Pathak S, Meng WJ, Nandy SK, Ping J, Bisgin A, Helmfors L, Waldmann P, Sun XF.
    Oncotarget; 2015 Dec 29; 6(42):44758-80. PubMed ID: 26556872
    [Abstract] [Full Text] [Related]

  • 11. Grey-white matter abnormalities in temporal lobe epilepsy associated with hippocampal sclerosis: Inter-observer analysis, histopathological findings, and correlation with clinical variables.
    Kuba R, Tyrlíková I, Pažourková M, Hermanová M, Horáková I, Brázdil M, Rektor I.
    Epilepsy Res; 2012 Nov 29; 102(1-2):78-85. PubMed ID: 22738717
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus.
    Bencurova P, Baloun J, Musilova K, Radova L, Tichy B, Pail M, Zeman M, Brichtova E, Hermanova M, Pospisilova S, Mraz M, Brazdil M.
    Epilepsia; 2017 Oct 29; 58(10):1782-1793. PubMed ID: 28815576
    [Abstract] [Full Text] [Related]

  • 13. Impact of focal cortical dysplasia Type IIIa on seizure outcome following anterior mesial temporal lobe resection for the treatment of epilepsy.
    Dührsen L, Sauvigny T, House PM, Stodieck S, Holst B, Matschke J, Schön G, Westphal M, Martens T.
    J Neurosurg; 2018 Jun 29; 128(6):1668-1673. PubMed ID: 28753112
    [Abstract] [Full Text] [Related]

  • 14. Functional substrate for memory function differences between patients with left and right mesial temporal lobe epilepsy associated with hippocampal sclerosis.
    Jin SH, Chung CK.
    Epilepsy Behav; 2015 Oct 29; 51():251-8. PubMed ID: 26300534
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic response function (HRF) in epilepsy patients with hippocampal sclerosis and focal cortical dysplasia.
    Watanabe S, An D, Safi-Harb M, Dubeau F, Gotman J.
    Brain Topogr; 2014 Sep 29; 27(5):613-9. PubMed ID: 24718726
    [Abstract] [Full Text] [Related]

  • 16. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, Di Gennaro GC, Esposito V, Spliet WG, van Rijen PC, Troost D, Gorter JA, Aronica E.
    Neuroscience; 2010 May 19; 167(3):929-45. PubMed ID: 20219643
    [Abstract] [Full Text] [Related]

  • 17. Doublecortin expression in focal cortical dysplasia in epilepsy.
    Srikandarajah N, Martinian L, Sisodiya SM, Squier W, Blumcke I, Aronica E, Thom M.
    Epilepsia; 2009 Dec 19; 50(12):2619-28. PubMed ID: 19583780
    [Abstract] [Full Text] [Related]

  • 18. Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance.
    Kaalund SS, Venø MT, Bak M, Møller RS, Laursen H, Madsen F, Broholm H, Quistorff B, Uldall P, Tommerup N, Kauppinen S, Sabers A, Fluiter K, Møller LB, Nossent AY, Silahtaroglu A, Kjems J, Aronica E, Tümer Z.
    Epilepsia; 2014 Dec 19; 55(12):2017-27. PubMed ID: 25410734
    [Abstract] [Full Text] [Related]

  • 19. Childhood onset temporal lobe epilepsy: Beyond hippocampal sclerosis.
    Mühlebner A, Breu M, Kasprian G, Schmook MT, Stefanits H, Scholl T, Samueli S, Gröppel G, Dressler A, Prayer D, Czech T, Hainfellner JA, Feucht M.
    Eur J Paediatr Neurol; 2016 Mar 19; 20(2):228-235. PubMed ID: 26791392
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.